| Gallbladder Adenocarcinoma studied in …STUDIED_INderived17 of 17show fewer |
|---|
| → studied in | NCT05482516Phase 3 · recruiting Evaluating Novel Therapies in ctDNA Positive GI Cancers · condition mapped ONTOLOGY_EXACT · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07282912Phase 2 · recruiting Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels · condition mapped ONTOLOGY_EXACT · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07765433Phase 2/Phase 3 · not yet recruiting Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer · condition mapped CURATED_BROADER · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03257761Phase 1 · active not recruiting Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma, Biliary Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04931420Phase 2 · withdrawn Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels · condition mapped ONTOLOGY_EXACT · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01825603Phase 1 · completed ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01643499Phase 1 · completed Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03267940Phase 1 · terminated Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00478140Phase 2 · terminated Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00142480Phase 2 · completed Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085410Phase 2 · terminated Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00361231Phase 2 · completed Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01267344Phase 2 · completed A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01093222Phase 2 · completed Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01859182Phase 2 · withdrawn Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028496Phase 1 · completed Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238212Phase 2 · completed S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |